Expression and characterization of a β-fructofuranosidase from the parasitic protist Trichomonas vaginalis
- Michael Dirkx†1,
- Michael P Boyer†1,
- Prajakta Pradhan2,
- Andrew Brittingham2 and
- Wayne A Wilson1Email author
© Dirkx et al.; licensee BioMed Central Ltd. 2014
Received: 17 March 2014
Accepted: 25 June 2014
Published: 28 June 2014
Trichomonas vaginalis, a flagellated protozoan, is the agent responsible for trichomoniasis, the most common nonviral sexually transmitted infection worldwide. A reported 200 million cases are documented each year with far more cases going unreported. However, T. vaginalis is disproportionality under studied, especially considering its basic metabolism. It has been reported that T. vaginalis does not grow on sucrose. Nevertheless, the T. vaginalis genome contains some 11 putative sucrose transporters and a putative β-fructofuranosidase (invertase). Thus, the machinery for both uptake and cleavage of sucrose appears to be present.
We amplified the β-fructofuranosidase from T. vaginalis cDNA and cloned it into an Escherichia coli expression system. The expressed, purified protein was found to behave similarly to other known β-fructofuranosidases. The enzyme exhibited maximum activity at pH close to 5.0, with activity falling off rapidly at increased or decreased pH. It had a similar Km and Vmax to previously characterized enzymes using sucrose as a substrate, was also active towards raffinose, but had no detectable activity towards inulin.
T. vaginalis has the coding capacity to produce an active β-fructofuranosidase capable of hydrolyzing di- and trisaccharides containing a terminal, non-reducing fructose residue. Since we cloned this enzyme from cDNA, we know that the gene in question is transcribed. Furthermore, we could detect β-fructofuranosidase activity in T. vaginalis cell lysates. Therefore, the inability of the organism to utilize sucrose as a carbon source cannot be explained by an inability to degrade sucrose.
Trichomonas vaginalis is the causative agent of trichomoniasis, the most common non-viral sexually transmitted infection worldwide, with over 3 million cases estimated per year in the United States alone . In general, infected men are asymptomatic . However, in women, symptoms of infection may include vaginal discomfort, pain during intercourse and urination, and a thick, yellow, purulent discharge . In most instances, T. vaginalis infection is readily treated with the nitroimidazole drugs metronidazole or tinidazole . Likely due in part to the ease with which T. vaginalis infections can be treated the disease has been viewed historically as a ‘nuisance’ infection. However, it is now appreciated that infection with T. vaginalis predisposes patients to infection with HIV and other sexually transmitted diseases and may also be associated with infertility and adverse pregnancy outcomes [4, 5].
Despite decades of study, there are basic questions regarding the biochemistry of this important organism that remain unanswered. We are particularly interested in the means employed by T. vaginalis to secure essential nutrients from the environment and are addressing this question through in vitro culture of the protist.
As is the case with many parasitic protists, T. vaginalis lacks the capacity to synthesize many key metabolites such as saturated/unsaturated fatty acids and purines and pyrimidines . Cultivation of the organism therefore requires use of a complex growth medium [7, 8]. The preferred energy source is carbohydrate, although energy-yielding pathways utilizing a variety of amino acids have been identified [6, 9, 10].
Early work with axenic cultures of T. vaginalis demonstrated that glucose, maltose, and glucose polymers such as starch and glycogen, were capable of supporting robust growth [11, 12]. The glucose-containing disaccharides lactose and sucrose could not support growth, nor could the glucose-containing trisaccharide raffinose [11, 12]. Data relating to the utilization of other mono- and disaccharides is harder to interpret.
Read reported that trehalose, the α1,1 disaccharide of glucose, and melibiose, the α1,6 disaccharide of galactose and glucose, were utilized for growth , contradicting earlier studies by Trussell and Johnson . Of the monosaccharides other than glucose that have been tested (galactose, mannose, fructose, xylose, and arabinose), only galactose has been consistently reported to support growth [11, 12].
Growth using maltose as a carbon source has been especially well studied in T. vaginalis [13, 14]. Work by ter Kuile showed that the organism expresses cell-associated maltase activity that cleaves maltose to yield two molecules of glucose, which are then transported into the cell [14, 15]. However, other than two preliminary reports of amylase activity associated with the cells, the means by which other disaccharides and more complex carbohydrates are utilized by the organism remains largely uninvestigated [16, 17].
The publication of the T. vaginalis G3 strain genome sequence in 2007 has provided a wealth of information to guide biochemical investigation . For example, there are a variety of open reading frames that are proposed to encode α- or β-amylases, which could potentially explain the ability of T. vaginalis to grow using glycogen or starch [18, 19]. Intriguingly, one open reading frame, TVAG_254130, was annotated as a putative β-fructofuranosidase [18, 19].
The β-fructofuranosidases (EC 188.8.131.52; commonly referred to as invertases) catalyze the removal of fructose residues from the non-reducing ends of fructose-containing oligo- and/or polysaccharides . The preferred substrate for many such enzymes is sucrose, hydrolysis therefore generating an equimolar mixture of glucose and fructose. In addition to this potential β-fructofuranosidase, some 11 putative proteins, whose closest relatives were sucrose transporters found in plants, are encoded by the T. vaginalis genome [18, 19]. There is evidence from protein mass spectroscopy that at least some of these sucrose transporters are expressed (Mass Spec of T.vaginalis peptides from Richard Hayes, Patricia Johnson laboratory [version: 2009-05-27] accessed via the TrichDB database [19, 21]). Thus, while T. vaginalis fails to utilize sucrose as a carbon source, it appears that it may encode the enzymes required to do so.
Here, we describe the cloning of TVAG_254130 and the expression and characterization of its protein product. We established that the TVAG_254130 open reading frame is expressed in T. vaginalis. We also determined that β-fructofuranosidase activity could be detected in cell lysates of T. vaginalis. We went on to express and purify the product of the TVAG_254130 open reading frame from E. coli and determined that it encoded a β-fructofuranosidase with robust catalytic activity towards both sucrose and raffinose. Thus, the inability of sucrose to support the growth of T. vaginalis is not due to a lack of capacity to degrade this disaccharide.
Growth and maintenance of trichomonads
Trichomonas vaginalis G3 (ATCC PRA-98; Taxonomy ID: 412133) and Pentatrichomonas hominis Hs-3:NIH (ATCC 30000) were obtained from the American Type Culture Collection (Manassas, VA). Stock cultures were grown in a trypticase-yeast-extract-maltose (TYM) medium modified in our laboratory from a recipe first described by Hollander (see [22, 23] for details). Routine culture of T. vaginalis was carried out in 25 cm2 tissue culture flasks containing 5 to 10 ml of medium whereas P. hominis grew best in 100 mm screw top borosilicate glass culture tubes filled with 12 ml of medium. Both organisms were grown at 35°C. Cell growth and viability were determined by counting the number of intact and motile trichomonads in an aliquot using a Neubauer hemocytometer. All stock cultures were inoculated at a density of 1.0 x 105 cells/ml and were passaged every 48-72 hr. Under these growth conditions, the peak cell density averaged 3.6 x 106 cells/ml.
Synthesis of T. vaginalis cDNA and verification of expression of the TVAG_254130 open reading frame
T. vaginalis G3 was grown for 40 hr in TYM under our standard culture conditions described above. Total RNA was isolated using the SV Total RNA Isolation System (Promega, Madison, WI), according to the manufacturer’s instructions. The RNA was divided into aliquots and stored frozen at -80°C prior to use. For verification of expression of the TVAG_254130 open reading frame, one aliquot of RNA was treated with the Affinity QPCR cDNA Synthesis Kit (Agilent, Santa Clara, CA) to generate cDNA whilst a second aliquot was treated similarly but with reverse transcriptase omitted from the reaction mixture. Aliquots of the cDNA synthesis reaction and mock reaction lacking reverse transcriptase were then employed as the template in PCR reactions with primers designed to amplify the TVAG_254130 open reading frame, as described below.
Cloning and expression of the TVAG_254130 open reading frame
PCR primers WW98 (catatgaatttttcctcacgactaaaattccattttgagcc) and WW99 (gtcgacctaaaatagccaagtgctgtaataaaattcg) were designed to amplify the coding sequence of the TVAG_254130 open reading frame. Primer WW98 introduced an Nde I site at the start codon of the open reading frame and primer WW99 introduced a Sal I site immediately 3’ of the stop codon in order to ultimately facilitate cloning into the pET-28a bacterial expression system (EMD Millipore, Billerica, MA). For cloning of TVAG_254130 the template for PCR was cDNA prepared from the total RNA isolated as described above, but in this case cDNA synthesis was conducted using the ImProm-II Reverse Transcription System (Promega). Ex-Taq polymerase (Clontech Laboratories Inc., Mountain View, CA) was used in the PCR procedure to amplify TVAG_254130. The PCR product obtained was cloned into the pCR2.1-TOPO vector using the TOPO TA Cloning Kit (Life Technologies Corp, Carlsbad, CA) and then sequenced. The sequence obtained was identical to that reported by the T. vaginalis genome sequencing project. The PCR product was excised from the pCR2.1-TOPO vector with Nde I and Sal I and cloned into Nde I/Sal I cut pET-28a. The choice of cloning sites resulted in the incorporation of vector sequence encoding an affinity purification tag of six consecutive histidine residues into the 5’ end of the TVAG_254130 open reading frame. The N-terminal sequence of the recombinant protein was thus extended by the sequence MGSSHHHHHHSSGLVPRGSH. The pET-28a vector containing TVAG_254130 was transformed into E. coli strain BL21(DE3) for expression of recombinant protein.
The transformed BL21(DE3) were grown at 37°C in 500 ml of LB medium supplemented with kanamycin sulphate (50 μg/ml) until an OD600 nm of 0.6 was reached. Protein expression was then induced by the addition of isopropyl-β-D-thiogalactopyranoside to 1 mM, and the cultures were transferred to 30˚C. After 16 h of induction, cells were collected by centrifugation (5,000 x g, 10 minutes, 4˚C), washed and then resuspended with homogenization buffer (50 mM Tris-HCl pH 8.0, 50 mM NaCl, 5% v/v glycerol, 0.5 μg/ml leupeptin, 1 μg/ml pepstatin, 1 μg/ml aprotinin, 1 mM benzamidine HCl, 0.1 mM TLCK and 1 mM PMSF). Benzonase nuclease (EMD Millipore) was added to reduce viscosity and cell lysis was achieved by addition of rLysozyme solution (EMD Millipore). The cell suspension was incubated for 20 min at room temperature with gentle rocking. Cell debris was removed by centrifugation at 18,000 x g for 15 min at 4°C. The supernatant containing soluble recombinant β-fructofuranosidase was decanted, filtered through a 0.45 μm pore size syringe end filter, and applied to a Bio-Scale Mini Profinity IMAC cartridge attached to a BioLogic LP chromatography system (Bio-Rad, Hercules, CA) equilibrated with column buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 5 mM imidazole). The column was washed with 20 ml of column buffer, followed by 20 ml of column buffer with the imidazole concentration increased to 10 mM. The recombinant β-fructofuranosidase was eluted from the column by washing with 20 ml of column buffer with the imidazole concentration increased to 250 mM. Fractions containing β-fructofuranosidase activity were pooled together and dialyzed against storage buffer (50 mM HEPES pH 7.0, 50 mM NaCl) then concentrated to approximately 5 mg/ml protein using an Amicon Ultra-4 centrifugal filter unit (EMD Millipore). Glycerol was added to a final concentration of 20% (v/v). The purified β-fructofuranosidase was stored frozen at -80°C, where it was stable for at least 8 months.
Measurement of β-fructofuranosidase activity
β-Fructofuranosidase activity was assayed using a modification of published procedures . In brief, for studies using purified enzyme, the β-fructofuranosidase was diluted with sodium acetate buffer (20 mM sodium acetate, 50 mM NaCl, 0.05% v/v Triton X-100, pH 5.0) to a protein concentration of approximately 6 μg/ml. The diluted enzyme was then combined with sucrose or raffinose that had been dissolved in sodium acetate buffer without Triton X-100 in a total volume of 100 μl. This gave a final enzyme concentration in the reaction of ~ 27 nM. Control reactions contained sucrose or raffinose but no added enzyme. The samples were incubated at 30°C for 15 min and the reactions were then terminated by incubation in a dry block set to 100°C for 3 min. The samples were cooled on ice and the glucose released by hydrolysis of sucrose was measured in a coupled enzyme assay employing hexokinase and glucose-6-phosphate dehydrogenase . Under these conditions and at a substrate concentration of 250 mM, the rate of glucose production was linear with respect to time for at least 60 min. The action of β-fructofuranosidase on raffinose liberates fructose, which was measured using the same coupled enzyme assay as for glucose but with the addition of 3 U of phosphoglucose isomerase (Sigma-Aldrich, St. Louis, MO) per reaction. When examining the ability of T. vaginalis and P. hominis cells extracts to degrade sucrose, we grew the organisms under our standard conditions for 40 hrs until a density of approximately 2.5 × 106 cells/ml was reached. Cells were then collected from 10 ml of medium by centrifugation and lysed by the addition of 200 μl of ice cold lysis buffer (25 mM HEPES, 50 mM NaCl, pH 7.0) supplemented with 1 μg/ml leupeptin, 1 μg/ml pepstatin, 1 mM benzamidine-HCl, 0.1 mM TLCK, and 1 mM PMSF. Aliquots of cell lysate were then incubated at 30°C for 30 min with or without the addition of exogenous sucrose (250 mM). Control reactions contained 250 mM sucrose but no cell lysate. Following this incubation period, the glucose and fructose present in the samples was determined by coupled enzyme assay as described above.
Analysis of enzyme kinetic data
To estimate the Km and Vmax when either sucrose or raffinose was used as substrate, purified β-fructofuranosidase (~27 nM final concentration) was incubated at 30°C in 20 mM sodium acetate buffer pH 5.0 with varying concentrations of substrate, obtained by serial dilution of a concentrated stock solution prepared in the same buffer. For sucrose, the concentrations used ranged from 0.488 mM to 250 mM whereas a range of 0.156 mM to 100 mM was used for raffinose. The initial rate of sucrose or raffinose hydrolysis was determined by enzymatic measurement of the glucose or fructose released, as described above. The kinetic parameters were then estimated by directly fitting the data to the Michaelis-Menten equation using the Enzyme Kinetics module of SigmaPlot 11 (Systat Software Inc., San Jose, CA).
Sucrose fails to support the growth of T. vaginalis under our standard culture conditions
Cell extracts prepared from T. vaginalis contain an activity that hydrolyzes sucrose
Generation of glucose and fructose from exogenous sucrose by extracts of T. vaginalis
Glucose/fructose formed (nmol/min/mg)
38.5 ± 1.4
52.4 ± 4.6
56.0a ± 2.3
172a ± 13.8
The open reading frame TVAG_254130, encoding a putative β-fructofuranosidase is expressed in T. vaginalis under our standard growth conditions
TVAG_254130 encodes an active β-fructofuranosidase
In order to determine if TVAG_254130 encoded an active β-fructofuranosidase, we cloned the open reading frame into an E. coli expression system. Upon induction of expression, we could detect robust hydrolytic activity towards sucrose in extracts transformed with vector containing TVAG_254130 (~10 μmol/min/mg) and there was no detectable activity in extracts from cells transformed with empty expression vector. Thus, TVAG_254130 encodes an active β-fructofuranosidase.
Kinetic properties of the T. vaginalis β-fructofuranosidase
Kinetic properties of recombinant T. vaginalis β-fructofuranosidase
Turnover number (s -1) †
20.6 ± 2.2
1576 ± 48
1156 ± 36
5.5 ± 0.9
368 ± 16
270 ± 12
We have established that extracts prepared from T. vaginalis cells grown under standard laboratory conditions with maltose as a carbon source have some capacity to hydrolyze sucrose, liberating glucose and fructose. Furthermore, we determined that the open reading frame TVAG_254130, predicted to encode a β-fructofuranosidase activity, is expressed under these same growth conditions. Lastly, when expressed in E. coli, the TVAG_254130 open reading frame yields a β-fructofuranosidase activity with robust activity towards sucrose and raffinose. Thus, it would appear reasonable to propose that the β-fructofuranosidase encoded by TVAG_254130 may well be responsible for the sucrose-degrading activity observed in the cell lysates. This degradative capacity notwithstanding, sucrose did not support the growth of T. vaginalis.
What accounts for the lack of growth on sucrose? To address this question, first consider how sucrose is used by other organisms. In the mammalian digestive system, sucrose is hydrolyzed to glucose and fructose by sucrase-isomaltase, an integral membrane protein preferentially expressed by enterocytes of the intestinal brush border membrane [33, 34]. The glucose and fructose released are then transported into the enterocyte via specific carrier proteins for subsequent metabolism. Similarly, in the budding yeast Saccharomyces cerevisae, β-fructofuranosidase activity is secreted into the periplasmic space and sucrose is hydrolyzed there, the resulting monosaccharides being transported into the cell . In other organisms, including many bacteria (see [35–38] for selected examples), plants (reviewed in ), some plant pathogenic fungi , and perhaps some insects , sucrose is transported into the cell by means of sucrose transport systems and then cleaved by internal β-fructofuranosidase activities. Although we detected β-fructofuranosidase activity associated with extracts of T. vaginalis, we were unable to determine any activity associated with growth medium in which T. vaginalis had been grown for 40 hr. While this observation does not allow us to formally exclude the possibility that some β-fructofuranosidase activity was secreted by the cells, we believe that this is likely not the case. Thus, we think it most probable that in order for T. vaginalis to utilize sucrose, it would first be transported into the cell.
The T. vaginalis genome sequence indicates coding capacity for 11 proteins that, based upon sequence similarity, are proposed to be sucrose transporters . These proteins resemble known sucrose transporters from a variety of plants, as well as putative sucrose transporters from protists, such as Dictyostelium sp., and bacteria. There is evidence from mass spectroscopy of T. vaginalis-derived peptides that at least three of these open reading frames are expressed (Mass Spec of T.vaginalis peptides from Richard Hayes, Patricia Johnson laboratory (version: 2009-05-27) accessed via the TrichDB database [19, 21]). However, there is no direct experimental evidence that any of the putative sucrose transporter functions as such.
Regardless of the functionality or otherwise of these putative proteins in sucrose uptake, the presence of mRNA for TVAG_254130 in maltose-grown T. vaginalis and measurable β-fructofuranosidase activity in extracts from these same cells leads us to hypothesize that sucrose does not support growth of T. vaginalis under the conditions tested because it fails to enter the cells. This does not, of course, indicate that sucrose can never be used by T. vaginalis, only that sucrose was not utilized under the growth conditions that we tested.
The natural habitat of T. vaginalis is the urogenital tract of both males and females and the most robust growth and proliferation occurs in the vagina . Vaginal fluid contains a wealth of nutrients, including free amino acids, lipids, glucose, and other carbohydrates . However, it is unclear where the organism would encounter sucrose or other fructose-containing compounds. It is interesting to note here that T. vaginalis is somewhat unusual in being unable to catabolize sucrose as several related organisms grow well with this carbon source. For example P. hominis, an inhabitant of the human large intestine, can grow using sucrose as a carbon source (; our unpublished observations). Similarly T. foetus, best studied as a pathogen of the urogenital tract of cattle but now recognized as an important cause of feline diarrhea, also grows using sucrose [43–45]. Lastly, two trichomonads that infect the gastrointestinal tract of birds, T. gallinae and T. gallinarum can also use sucrose [12, 46]. All of these organisms inhabit or can inhabit a niche where sucrose, raffinose, or other plant-derived oligosaccharides containing fructose might be found. It is likely that the most recent common ancestor of T. vaginalis was a gut-dwelling protist, where the capacity to utilize fructose-containing compounds might be advantageous . Thus, T. vaginalis may retain the coding capacity and/or enzymatic activity to catabolize material that was abundant in an ancestral environment. The apparent drive towards increased genome size and increased cell size in T. vaginalis compared to related trichomonads  would mean that there was no pressure to lose such coding capacity, leading to the persistence of these ancestral sequences.
This research was supported in part by the Iowa Osteopathic Education & Research Foundation.
- Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J, Xu F, Weinstock H: Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013, 40 (3): 187-193. 10.1097/OLQ.0b013e318286bb53.PubMedView ArticleGoogle Scholar
- Petrin D, Delgaty K, Bhatt R, Garber G: Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998, 11 (2): 300-317.PubMedPubMed CentralGoogle Scholar
- Workowski KA, Berman SM: Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. Clin Infect Dis. 2011, 53 (Suppl 3): S59-S63. 10.1093/cid/cir694.PubMedView ArticleGoogle Scholar
- McClelland RS: Trichomonas vaginalis infection: can we afford to do nothing?. J Infect Dis. 2008, 197 (4): 487-489. 10.1086/526498.PubMedPubMed CentralView ArticleGoogle Scholar
- Cotch MF, JG, 2nd P, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG: Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997, 24 (6): 353-360. 10.1097/00007435-199707000-00008.PubMedView ArticleGoogle Scholar
- Muller M: Biochemistry of Trichomonas vaginalis. Trichomonads Parasitic in Humans. Edited by: Honigberg BM. 1989, New York: Springer, 53-83.Google Scholar
- Diamond LS: The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol. 1957, 43 (4): 488-490.PubMedView ArticleGoogle Scholar
- Clark CG, Diamond LS: Methods for cultivation of luminal parasitic protists of clinical importance. Clin Microbiol Rev. 2002, 15 (3): 329-341. 10.1128/CMR.15.3.329-341.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Thong KW, Coombs GH, Sanderson BE: L-methionine catabolism in trichomonads. Mol Biochem Parasitol. 1987, 23 (3): 223-231. 10.1016/0166-6851(87)90029-6.PubMedView ArticleGoogle Scholar
- Zuo X, Lockwood BC, Coombs GH: Uptake of amino acids by the parasitic, flagellated protist Trichomonas vaginalis. Microbiology. 1995, 141 (Pt 10): 2637-2642.PubMedView ArticleGoogle Scholar
- Trussell RE, Johnson G: Physiology of pure cultures of Trichomonas vaginalis: III. Fermentation of carbohydrates and related compounds. Proc Soc Exp Biol Med. 1941, 47: 176-178. 10.3181/00379727-47-13076.View ArticleGoogle Scholar
- Read CP: Comparative studies on the physiology of Trichomonad Protozoa. J Parasitol. 1957, 43 (4): 385-394. 10.2307/3274661.PubMedView ArticleGoogle Scholar
- ter Kuile BH: Carbohydrate metabolism and physiology of the parasitic protist Trichomonas vaginalis studied in chemostats. Microbiology. 1994, 140 (Pt 9): 2495-2502.PubMedView ArticleGoogle Scholar
- ter Kuile BH, Muller M: Maltose utilization by extracellular hydrolysis followed by glucose transport in Trichomonas vaginalis. Parasitology. 1995, 110 (Pt 1): 37-44.PubMedView ArticleGoogle Scholar
- Ter Kuile BH, Hrdy I, Sanchez LB, Muller M: Purification and specificity of two alpha-glucosidase isoforms of the parasitic protist Trichomonas vaginalis. J Eukaryot Microbiol. 2000, 47 (5): 440-442. 10.1111/j.1550-7408.2000.tb00072.x.PubMedView ArticleGoogle Scholar
- Adler S: The presence of amylase in the karyoplasm of Trichomonas vaginalis. Acta Med Orient. 1953, 12: 204-205.PubMedGoogle Scholar
- Takayanagi T, Enriquez GL, Kambara H: An electrophoretic study of the amylase of Trichomonas vaginalis. Southeast Asian J Trop Med Public Health. 1971, 2: 308-312.PubMedGoogle Scholar
- Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, Wortman JR, Bidwell SL, Alsmark UC, Besteiro S, Sicheritz-Ponten T, Noel CJ, Dacks JB, Foster PG, Simillion C, Van de Peer Y, Miranda-Saavedra D, Barton GJ, Westrop GD, Muller S, Dessi D, Fiori PL, Ren Q, Paulsen I, Zhang H, Bastida-Corcuera FD, Simoes-Barbosa A, Brown MT, Hayes RD, Mukherjee M: Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science. 2007, 315 (5809): 207-212. 10.1126/science.1132894.PubMedPubMed CentralView ArticleGoogle Scholar
- TrichDB Trichomonas Genomics Resource. [http://trichdb.org/trichdb/]
- Schomburg D, Salzmann M: β-fructofuranosidase. Enzyme Handbook 4. Edited by: Schomburg D, Salzmann M. 1991, Berlin Heidelberg: Springer, 179-188.View ArticleGoogle Scholar
- Aurrecoechea C, Brestelli J, Brunk BP, Carlton JM, Dommer J, Fischer S, Gajria B, Gao X, Gingle A, Grant G, Harb OS, Heiges M, Innamorato F, Iodice J, Kissinger JC, Kraemer E, Li W, Miller JA, Morrison HG, Nayak V, Pennington C, Pinney DF, Roos DS, Ross C, Stoeckert CJ, Sullivan S, Treatman C, Wang H: GiardiaDB and TrichDB: integrated genomic resources for the eukaryotic protist pathogens Giardia lamblia and Trichomonas vaginalis. Nucleic Acids Res. 2009, 37 (Database issue): D526-D530.PubMedPubMed CentralView ArticleGoogle Scholar
- Hollander DH: Colonial morphology of Trichomonas vaginalis in Agar. J Parasitol. 1976, 62 (5): 826-828. 10.2307/3278971.PubMedView ArticleGoogle Scholar
- Nielsen TJ, Pradhan P, Brittingham A, Wilson WA: Glycogen accumulation and degradation by the trichomonads Trichomonas vaginalis and Trichomonas tenax. J Eukaryot Microbiol. 2012, 59 (4): 359-366. 10.1111/j.1550-7408.2012.00624.x.PubMedView ArticleGoogle Scholar
- Goldstein A, Lampen JO: β-D-fructofuranoside fructohydrolase from yeast. Methods in Enzymology. Edited by: Wood WA. 1975, Volume 76: 504-511.View ArticleGoogle Scholar
- Hardy TA, Huang D, Roach PJ: Interactions between cAMP-dependent and SNF1 protein kinases in the control of glycogen accumulation in Saccharomyces cerevisiae. J Biol Chem. 1994, 269 (45): 27907-27913.PubMedGoogle Scholar
- Wenrich DH: The species of trichomonas in man. J Parasitol. 1947, 33: 177-178. 10.2307/3273547.PubMedView ArticleGoogle Scholar
- Honigberg BM: Evolutionary and systematic relationships in the flagellate order Trichomonadida. J Protozool. 1963, 10: 20-63. 10.1111/j.1550-7408.1963.tb01635.x.PubMedView ArticleGoogle Scholar
- Honigberg BM: Taxonomy and Nomenclature. Trichomonads Parasitic In Humans. Edited by: Honigberg BM. 1989, New York: Springer-Verlag, 3-4.Google Scholar
- Solomon JM: Studies on the physiology of Trichomonas hominis. J Parasitol. 1957, 43 (5 (Supplement)): 39-Google Scholar
- Schomburg I, Chang A, Placzek S, Söhngen C, Rother M, Lang M, Munaretto C, Ulas S, Stelzer M, Grote A, Scheer M, Schomburg D: BRENDA in 2013: integrated reactions, kinetic data, enzyme function data, improved disease classification: new options and contents in BRENDA. Nucleic Acids Res. 2013, 41 (D1): D764-D772. 10.1093/nar/gks1049.PubMedPubMed CentralView ArticleGoogle Scholar
- BRENDA - the enzyme database. [http://www.brenda-enzymes.org]
- Gascón S, Neumann NP, Lampen JO: Comparative study of the properties of the purified internal and external invertases from yeast. J Biol Chem. 1968, 243 (7): 1573-1577.PubMedGoogle Scholar
- Leturque A, Brot-Laroche E, Le Gall M: Carbohydrate intake. Prog Mol Biol Transl Sci. 2012, 108: 113-127.PubMedView ArticleGoogle Scholar
- Hauser H, Semenza G: Sucrase-isomaltase: a stalked intrinsic protein of the brush border membrane. CRC Crit Rev Biochem. 1983, 14 (4): 319-345. 10.3109/10409238309102798.PubMedView ArticleGoogle Scholar
- Slee AM, Tanzer JM: Phosphoenolpyruvate-dependent sucrose phosphotransferase activity in Streptococcus mutans NCTC 10449. Infect Immun. 1979, 24 (3): 821-828.PubMedPubMed CentralGoogle Scholar
- Schmid K, Schupfner M, Schmitt R: Plasmid-mediated uptake and metabolism of sucrose by Escherichia coli K-12. J Bacteriol. 1982, 151 (1): 68-76.PubMedPubMed CentralGoogle Scholar
- Titgemeyer F, Jahreis K, Ebner R, Lengeler JW: Molecular analysis of the scrA and scrB genes from Klebsiella pneumoniae and plasmid pUR400, which encode the sucrose transport protein Enzyme II Scr of the phosphotransferase system and a sucrose-6-phosphate invertase. Mol Gen Genet. 1996, 250 (2): 197-206.PubMedGoogle Scholar
- Reizer J, Bachem S, Reizer A, Arnaud M, Saier MH, Stulke J: Novel phosphotransferase system genes revealed by genome analysis - the complete complement of PTS proteins encoded within the genome of Bacillus subtilis. Microbiology. 1999, 145 (Pt 12): 3419-3429.PubMedView ArticleGoogle Scholar
- Kuhn C, Grof CP: Sucrose transporters of higher plants. Curr Opin Plant Biol. 2010, 13 (3): 288-298.PubMedView ArticleGoogle Scholar
- Wahl R, Wippel K, Goos S, Kamper J, Sauer N: A novel high-affinity sucrose transporter is required for virulence of the plant pathogen Ustilago maydis. PLoS Biol. 2010, 8 (2): e1000303-10.1371/journal.pbio.1000303.PubMedPubMed CentralView ArticleGoogle Scholar
- Meyer H, Vitavska O, Wieczorek H: Identification of an animal sucrose transporter. J Cell Sci. 2011, 124 (Pt 12): 1984-1991.PubMedView ArticleGoogle Scholar
- Huggins GR, Preti G: Vaginal odors and secretions. Clin Obstet Gynecol. 1981, 24 (2): 355-377. 10.1097/00003081-198106000-00005.PubMedView ArticleGoogle Scholar
- Rae DO, Crews JE: Tritrichomonas foetus . Vet Clin North Am Food Anim Pract. 2006, 22 (3): 595-611. 10.1016/j.cvfa.2006.07.001.PubMedView ArticleGoogle Scholar
- Tolbert MK, Gookin J: Tritrichomonas foetus: a new agent of feline diarrhea. Compend Contin Educ Vet. 2009, 31 (8): 374-381. 390; quiz 381PubMedGoogle Scholar
- Ryley JF: Studies on the metabolism of the protozoa. 5. Metabolism of the parasitic flagellate Trichomonas foetus. Biochem J. 1955, 59 (3): 361-369.PubMedPubMed CentralView ArticleGoogle Scholar
- Theodorides VJ: Axenic culture of Tetratrichomonas gallinarum: Growth and anaerobic utilization of carbohydrates and related compounds. Exp Parasitol. 1964, 15 (5): 397-402. 10.1016/0014-4894(64)90034-7.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.